mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
0.0087 |
0.8 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
0.0088 |
0.8 |
mRNA |
KH-CB19 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0073 |
0.8 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.8 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0079 |
0.8 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
-0.0068 |
0.8 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.0075 |
0.8 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
-0.0082 |
0.8 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |